These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8788769)
1. Potential mechanisms of interferon neurotoxicity. Bender CM; Monti EJ; Kerr ME Cancer Pract; 1996; 4(1):35-9. PubMed ID: 8788769 [TBL] [Abstract][Full Text] [Related]
2. Neurologic complications of cancer chemotherapy. Sul JK; Deangelis LM Semin Oncol; 2006 Jun; 33(3):324-32. PubMed ID: 16769421 [TBL] [Abstract][Full Text] [Related]
3. Further evidence of neurological sequelae associated with interferon therapy in the paediatric population. Murray DM; Hensey OJ; O'Dwyer TP; King MD Eur J Paediatr Neurol; 2000; 4(6):295-6. PubMed ID: 11277372 [No Abstract] [Full Text] [Related]
4. Neurologic complications of chemotherapy. Macdonald DR Neurol Clin; 1991 Nov; 9(4):955-67. PubMed ID: 1758434 [TBL] [Abstract][Full Text] [Related]
5. Neurologic, pulmonary, and cutaneous toxicities of high-dose chemotherapy. Armstrong T; Rust D; Kohtz JR Oncol Nurs Forum; 1997; 24(1 Suppl):23-33. PubMed ID: 9010862 [TBL] [Abstract][Full Text] [Related]
6. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy]. Nakane M Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694 [TBL] [Abstract][Full Text] [Related]
7. [Neurotoxicity with cytostatic therapy: a review]. Cerny T; Meier C Schweiz Med Wochenschr; 1989 Aug; 119(34):1137-47. PubMed ID: 2554491 [TBL] [Abstract][Full Text] [Related]
15. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Grill MF; Maganti R Ann Pharmacother; 2008 Dec; 42(12):1843-50. PubMed ID: 19033476 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction? Geffen DB; Liel-Cohen N Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640 [No Abstract] [Full Text] [Related]
17. [Problems in the clinical evaluation of interferon]. Zanussi C Ann Ist Super Sanita; 1987; 23(4):779-85. PubMed ID: 2454600 [No Abstract] [Full Text] [Related]
18. [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects]. Schäfer M; Schwaiger M Fortschr Neurol Psychiatr; 2003 Sep; 71(9):469-76. PubMed ID: 12975732 [TBL] [Abstract][Full Text] [Related]
19. Managing hematologic toxicities in the oncology patient. Montoya L J Infus Nurs; 2007; 30(3):168-72. PubMed ID: 17505218 [TBL] [Abstract][Full Text] [Related]